Insider Shareholders with Direct Ownership of Annexon, Inc. (ANNX)
This section provides a comprehensive overview of the insiders with direct ownership of Annexon, Inc. (ANNX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Annexon, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Douglas Love
PRESIDENT AND CEO |
383,487 | 47,476 | 351,554 $928,102 | 22 |
Feb 13, 2025
Reduced 1.41%
|
|
Michael Overdorf
EVP & CHIEF BUSINESS OFFICER |
124,813 | 14,750 | 86,579 $228,568 | 13 |
Feb 18, 2025
Reduced 7.1%
|
|
Dean Richard Artis
EVP & CHIEF SCIENTIFIC OFFICER |
83,963 | 5,515 | 83,814 $221,268 | 3 |
Feb 18, 2025
Reduced 6.17%
|
|
Jennifer Lew
EVP & CHIEF FINANCIAL OFFICER |
136,813 | 29,169 | 77,770 $205,312 | 19 |
Feb 18, 2025
Reduced 8.16%
|
|
Ted Yednock
EVP & CHIEF INNOVATION OFFICER |
157,736 | 89,421 | 61,237 $161,665 | 17 |
Feb 18, 2025
Reduced 11.99%
|
|
Jamie Dananberg
CHIEF MEDICAL OFFICER |
83,963 | 5,521 | 33,479 $88,384 | 3 |
Feb 18, 2025
Reduced 14.16%
|
| 25,600 | 0 | 25,600 $67,584 | 8 |
Dec 02, 2024
Added 11.11%
|
|
|
Larry Mattheakis
EVP & Chief Scientific Officer |
21,876 | 0 | 17,188 $45,376 | 2 |
Jul 11, 2022
Added 21.43%
|
|
Sanjay Keswani
EVP & Chief Medical Officer |
16,495 | 3,995 | 12,500 $33,000 | 3 |
Feb 11, 2022
Added 50.0%
|